Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RVU120 in Low-Risk MDS Anemia
NCT06243458Phase 2Active, not recruiting
- Sponsor
- GCP-Service International
- Start
- Sep 2024
- Primary completion
- May 2026
- Countries
- 5
01
Overview
A Phase 2 trial of rvu120 in myelodysplastic syndrome (MDS), sponsored by GCP-Service International. Started Sep 2024; status: active, not recruiting.
02
Drugs
rvu120
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT06243458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06243458.